JPMorgan maintains UBS stock Overweight rating and CHF37 target

JPMorgan reiterated its Overweight rating and CHF37.00 price target on UBS, but anticipates upcoming Swiss regulatory reforms concerning banking stability could increase UBS's capital requirements by potentially $20 billion if 100% coverage of foreign participations is mandated. This may decrease JPMorgan’s 2027 estimated return on CET1 capital for UBS from 16.1% to 14.3% and impact near-term shareholder payout potential, pending the details of the Swiss Federal Council's consultation on June 6 and subsequent regulatory approvals.

Analysis

JPMorgan has maintained its Overweight rating and CHF37.00 price target for UBS Group AG, despite anticipating significant regulatory headwinds from upcoming Swiss banking stability reforms. The Swiss Federal Council's public consultation, commencing June 6, is expected to propose new rules on the capital treatment of foreign participations, potentially mandating 100% coverage through going concern capital. This could necessitate an additional $20 billion in capital at the Parent Bank level for UBS, although this figure might reduce to $12.8 billion over time through capital repatriation from entities like Credit Suisse International and the U.S. Intermediate Holding Company, contingent on regulatory approvals. Such an increase in capital requirements could lower JPMorgan’s 2027 estimated return on CET1 capital (RoCET1) for UBS from 16.1% to 14.3%, based on a projected 16.6% CET1 ratio. An extreme scenario outlined by JPMorgan includes the potential elimination of $12 billion in share buybacks from 2026-27 estimates to address this capital shortfall, prompting JPMorgan to revisit its buyback assumptions post-proposal. Consequently, UBS Group's short-term shareholder payout potential is under scrutiny, as the allocation of upstreamed capital between resolving double leverage and shareholder distributions will depend on the operational level of equity double leverage UBS opts for. The overall sentiment surrounding these developments is mixed to cautious, with a specific negative sentiment for UBS noted, reflecting the uncertainty and potential financial implications of these regulatory changes.

Key Decisions for Investors

• Investors should closely monitor the outcome of the Swiss Federal Council's consultation on June 6 and subsequent regulatory pronouncements, as these will directly influence UBS's capital requirements and financial flexibility.
• It is advisable to re-evaluate UBS's shareholder return prospects, particularly concerning share buybacks and dividend sustainability, in light of the potential $12.8 billion to $20 billion capital increase and its impact on RoCET1, which JPMorgan estimates could fall to 14.3%.
• Consideration should be given to the downside risk presented by these regulatory changes to UBS's capital structure and profitability, while also noting JPMorgan's maintained Overweight rating and price target, which may indicate a belief in the bank's long-term ability to absorb these impacts or that current valuations offer a sufficient margin of safety.